Archived Seminar: Molecular Programs Defining Tumor-Specific T cell Dysfunction and Therapeutic Reprogrammability
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
You May Also Be Interested In...
Home ItemPioneers in Biomedical Research: Inter-Organelle Communication Pathways and Dynamics Revealed by Imaging , home
Sept. 9, 2022, 11 a.m. | Jennifer Lippincott-Schwartz, Ph.D. | Pioneers in Biomedical Research Seminar Series
Home ItemPioneers in Biomedical Research: Regulation of Endothelial Cell Specialization , home
Sept. 16, 2022, 11 a.m. | Karen K. Hirschi, Ph.D. | Pioneers in Biomedical Research Seminar Series
Home ItemMedical Scholar Lecture: Albinism: Can It Become a Treatable Disease? , home
Sept. 16, 2022, 1 to 2 p.m. | Brian Brooks, M.D., Ph.D. | Timothy A. Johnson Medical Scholar Lecture Series
Home ItemPublic Lecture: Socially-Directed Science and Technology: Design at the Intersection of History, Sustainability, and Equity with Applications to Biotechnology and Biomaterials , home
Sept. 22, 2022, 5:30 p.m. | Christine Ortiz, Ph.D. | Maury Strauss Distinguished Public Lecture
Home ItemPioneers in Biomedical Research: Connectomics of Addiction Recovery , home
Sept. 23, 2022, 11:00 am. | Sarah Yip, Ph.D. | Pioneers in Biomedical Research Seminar Series
Andrea Schietinger, Ph.D.
Sloan Kettering Cancer Institute